Document details
Form
Filing Date
Feb 5, 2024
Document Date
Feb 1, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Olema Oncology
Issuer
Olema Pharmaceuticals, Inc.
Filer
MYLES DAVID C.